Cargando…

Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands

Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have led to a renewed interest for human leukocyte antigen class I (HLA-I) binding peptides, given their potential use as peptide vaccines. Databases of HLA-I binding peptides hold therefore information on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez, Marta A. S., Bassani-Sternberg, Michal, Coukos, George, Gfeller, David, Zoete, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883762/ https://www.ncbi.nlm.nih.gov/pubmed/31824508 http://dx.doi.org/10.3389/fimmu.2019.02731

Ejemplares similares

Deciphering the landscape of phosphorylated HLA-II ligands
por: Solleder, Marthe, et al.
Publicado: (2022)

‘Hotspots’ of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization
por: Müller, Markus, et al.
Publicado: (2017)

Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference
por: Marino, Fabio, et al.
Publicado: (2020)

Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
por: Gfeller, David, et al.
Publicado: (2018)

Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity
por: Bassani-Sternberg, Michal, et al.
Publicado: (2017)

Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome*
por: Mylonas, Roman, et al.
Publicado: (2018)

High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
por: Chong, Chloe, et al.
Publicado: (2018)

SwissSidechain: a molecular and structural database of non-natural sidechains
por: Gfeller, David, et al.
Publicado: (2013)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction
por: Pak, HuiSong, et al.
Publicado: (2021)

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
por: Bassani-Sternberg, Michal, et al.
Publicado: (2019)

Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
por: Lill, Jennie R., et al.
Publicado: (2022)

P32. High resolution mass spectrometry reveals the depth and diversity of HLA-I peptidomes
por: Bassani-Sternberg, M, et al.
Publicado: (2014)

Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove
por: McMurtrey, Curtis, et al.
Publicado: (2016)

Editorial: Novel Strategies for Anti-Tumor Vaccines
por: Accolla, Roberto S., et al.
Publicado: (2020)

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
por: Marcu, Ana, et al.
Publicado: (2021)

Sensitive identification of neoantigens and cognate TCRs in human solid tumors
por: Arnaud, Marion, et al.
Publicado: (2021)

Understanding natural killer cell regulation by mathematical approaches
por: Watzl, Carsten, et al.
Publicado: (2012)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
por: Bassani-Sternberg, Michal, et al.
Publicado: (2015)

Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction
por: Wendorff, Mareike, et al.
Publicado: (2020)

Diversity of Natural Self-Derived Ligands Presented by Different HLA Class I Molecules in Transporter Antigen Processing-Deficient Cells
por: Lorente, Elena, et al.
Publicado: (2013)

Divergent Peptide Presentations of HLA-A(*)30 Alleles Revealed by Structures With Pathogen Peptides
por: Zhu, Shiyan, et al.
Publicado: (2019)

Simultaneous editing of TCR, HLA-I/II and HLA-E resulted in enhanced universal CAR-T resistance to allo-rejection
por: Li, Wuling, et al.
Publicado: (2022)

Maternal-Fetal HLA Compatibility in Uncomplicated and Preeclamptic Naturally Conceived Pregnancies
por: van ‘t Hof, Liseanne J., et al.
Publicado: (2021)

Hidden Patterns of Anti-HLA Class I Alloreactivity Revealed Through Machine Learning
por: Vittoraki, Angeliki G., et al.
Publicado: (2021)

HLA-DO and Its Role in MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Challenges and opportunities in analyzing and modeling peptide presentation by HLA-II proteins
por: ElAbd, Hesham, et al.
Publicado: (2023)

Effects of HLA single chain trimer design on peptide presentation and stability
por: Finton, Kathryn A. K., et al.
Publicado: (2023)

Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC
por: Wu, Ching-Lien, et al.
Publicado: (2021)

Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires
por: Scholz, Erika Margaret, et al.
Publicado: (2017)

Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines
por: Graciotti, Michele, et al.
Publicado: (2020)

Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19
por: Shkurnikov, Maxim, et al.
Publicado: (2021)

HLA-G and the MHC Cusp Theory
por: Scavuzzi, Bruna Miglioranza, et al.
Publicado: (2022)

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
por: Erbe, Amy K., et al.
Publicado: (2017)

Determining if T cell antigens are naturally processed and presented on HLA class I molecules
por: Friedman, Jay, et al.
Publicado: (2022)

HLA-H: Transcriptional Activity and HLA-E Mobilization
por: Jordier, François, et al.
Publicado: (2020)

The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection
por: Rajalingam, Raja
Publicado: (2016)

Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation
por: Schellens, Ingrid M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ri5pt058t5ht6aousn400fhf09